Suraksha Diagnostic has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 08 February 2025, at the registered office of the Company, to consider, approve and take on record the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended 31 December 2024. Further, in continuation to intimation letter dated Thursday, 26 December 2024, regarding closure of trading window for the aforesaid purpose, and in accordance with the Company's Internal Code of Conduct for Prohibition of Insider Trading, framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company is already closed from 01 January 2025 and shall continue to remain close for directors, KMP’s, designated persons, employees, connected persons and their immediate relatives until the expiry of 48 hours after the announcement of the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended 31 December 2024.
The above information is a part of company’s filings submitted to BSE.